Intellia Therapeutics (NTLA) PT Lowered to $30 at RBC Capital

May 9, 2025 10:38 AM EDT Send to a Friend

RBC Capital analyst Luca Issi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Intellia Therapeutics (NTLA) PT Lowered to $30 at RBC Capital

Member Login

Free News Feed